A study to assess the safety and efficacy of K-321 in participants with FECD after simultaneous cataract surgery and descemetorhexis.
- Investigator
- Sonal S Tuli
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
KOWA 303 -
KOWA 301 A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
- Investigator
- Sonal S Tuli
- Ages
- 18 Years - N/A
- Sexes
- All
-
JXR MEDI ASHB TILIA The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.
- Ages
- 18 Years - N/A
- Sexes
- All
-
UCB SL0043 The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.
- Investigator
- Michael R Bubb
- Ages
- 16 Years - N/A
- Sexes
- All
-
A Phase III randomised study to evaluate the efficacy and safety of olorofim versus AmBisome? for tr The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive…
- Investigator
- Gautam Kalyatanda
- Ages
- 18 Years - N/A
- Sexes
- All
-
BOSTON 3 The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.
- Investigator
- Amir M Emtiazjoo
- Ages
- 18 Years - N/A
- Sexes
- All
-
JXR MEDI ISAC RECOVER SLEEP The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and…
- Ages
- 18 Years - N/A
- Sexes
- All
-
RECOVER-AD This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This…
- Investigators
- Vidhu Kariyawasam, Kartik Cherabuddi
- Ages
- 18 Years - N/A
- Sexes
- All
-
Recover-neuro This platform protocol is designed to be flexible so that it is suitable for a wide range of settings within health care systems, for remote settings, and in community settings where it can be integrated into COVID-19 programs and subsequent…
- Ages
- 18 Years - N/A
- Sexes
- All